Overview

Five leading research institutions across New York — Roswell Park, the University of Rochester, Mount Sinai, NYU Langone, and Weill Cornell — have launched the Empire State Cellular Therapy Consortium to accelerate the development and delivery of cell-based treatments for cancer and other diseases. By pooling resources, sharing clinical trial networks, and leveraging specialized facilities like Roswell Park’s state-of-the-art cell manufacturing center, the consortium will expand patient access to innovative therapies, strengthen collaboration among scientists and clinicians, and position New York as a national leader in cell and gene therapy.